16 is that FGF-1 can bind heparin irrespective of the orientation ... to the puzzle of how heparin activates the FGF signaling pathway. A complete understanding of the role of heparin in ...
The novel anthraquinone compound Kanglexin (KLX) has been investigated for its potential to prevent EndMT in atherosclerosis by targeting the fibroblast growth factor receptor 1 (FGFR1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback